These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 31353223)

  • 41. The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms.
    Kabata H; Moro K; Koyasu S
    Immunol Rev; 2018 Nov; 286(1):37-52. PubMed ID: 30294963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of group 2 innate lymphoid cells exacerbates and confers corticosteroid resistance to mouse nasal type 2 inflammation.
    Morikawa T; Fukuoka A; Matsushita K; Yasuda K; Iwasaki N; Akasaki S; Fujieda S; Yoshimoto T
    Int Immunol; 2017 May; 29(5):221-233. PubMed ID: 28541554
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SLAM-family receptors promote resolution of ILC2-mediated inflammation.
    Wang Y; Quan Y; He J; Chen S; Dong Z
    Nat Commun; 2024 Jun; 15(1):5056. PubMed ID: 38871792
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuromedin U Suppresses Collagen-Induced Arthritis through ILC2-Th2 Activation.
    Zhang Y; Qin Y; Chen Z
    J Immunol Res; 2021; 2021():5599439. PubMed ID: 33748288
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostaglandin E
    Zhou Y; Wang W; Zhao C; Wang Y; Wu H; Sun X; Guan Y; Zhang Y
    Front Immunol; 2018; 9():501. PubMed ID: 29593738
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Keratinocytes express cytokines and nerve growth factor in response to neuropeptide activation of the ERK1/2 and JNK MAPK transcription pathways.
    Shi X; Wang L; Clark JD; Kingery WS
    Regul Pept; 2013 Sep; 186():92-103. PubMed ID: 23958840
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impaired basophil induction leads to an age-dependent innate defect in type 2 immunity during helminth infection in mice.
    Nel HJ; Hams E; Saunders SP; Mangan NE; Smith P; Atzberger A; Flavell RA; Akira S; McKenzie AN; Fallon PG
    J Immunol; 2011 Apr; 186(8):4631-9. PubMed ID: 21398616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IL-33-Responsive Group 2 Innate Lymphoid Cells Are Regulated by Female Sex Hormones in the Uterus.
    Bartemes K; Chen CC; Iijima K; Drake L; Kita H
    J Immunol; 2018 Jan; 200(1):229-236. PubMed ID: 29133293
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inflammatory group 2 innate lymphoid cells.
    Huang Y; Paul WE
    Int Immunol; 2016 Jan; 28(1):23-8. PubMed ID: 26232596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IL-25 simultaneously elicits distinct populations of innate lymphoid cells and multipotent progenitor type 2 (MPPtype2) cells.
    Saenz SA; Siracusa MC; Monticelli LA; Ziegler CG; Kim BS; Brestoff JR; Peterson LW; Wherry EJ; Goldrath AW; Bhandoola A; Artis D
    J Exp Med; 2013 Aug; 210(9):1823-37. PubMed ID: 23960191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense.
    Huang Y; Mao K; Chen X; Sun MA; Kawabe T; Li W; Usher N; Zhu J; Urban JF; Paul WE; Germain RN
    Science; 2018 Jan; 359(6371):114-119. PubMed ID: 29302015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterogeneity of ILC2s in the Intestine; Homeostasis and Pathology.
    Sunaga S; Tsunoda J; Teratani T; Mikami Y; Kanai T
    Front Immunol; 2022; 13():867351. PubMed ID: 35707544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolation and Identification of Group 2 Innate Lymphoid Cells in Settings of Type 2 Inflammation.
    Nussbaum JC; Ortiz-Carpena JF
    Methods Mol Biol; 2018; 1799():93-107. PubMed ID: 29956147
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C3a is required for ILC2 function in allergic airway inflammation.
    Gour N; Smole U; Yong HM; Lewkowich IP; Yao N; Singh A; Gabrielson E; Wills-Karp M; Lajoie S
    Mucosal Immunol; 2018 Nov; 11(6):1653-1662. PubMed ID: 30104625
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HpARI Protein Secreted by a Helminth Parasite Suppresses Interleukin-33.
    Osbourn M; Soares DC; Vacca F; Cohen ES; Scott IC; Gregory WF; Smyth DJ; Toivakka M; Kemter AM; le Bihan T; Wear M; Hoving D; Filbey KJ; Hewitson JP; Henderson H; Gonzàlez-Cìscar A; Errington C; Vermeren S; Astier AL; Wallace WA; Schwarze J; Ivens AC; Maizels RM; McSorley HJ
    Immunity; 2017 Oct; 47(4):739-751.e5. PubMed ID: 29045903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cells.
    Huang Y; Guo L; Qiu J; Chen X; Hu-Li J; Siebenlist U; Williamson PR; Urban JF; Paul WE
    Nat Immunol; 2015 Feb; 16(2):161-9. PubMed ID: 25531830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation.
    Molofsky AB; Van Gool F; Liang HE; Van Dyken SJ; Nussbaum JC; Lee J; Bluestone JA; Locksley RM
    Immunity; 2015 Jul; 43(1):161-74. PubMed ID: 26092469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system.
    Voehringer D; Reese TA; Huang X; Shinkai K; Locksley RM
    J Exp Med; 2006 Jun; 203(6):1435-46. PubMed ID: 16702603
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid Cells.
    Halim TYF; Rana BMJ; Walker JA; Kerscher B; Knolle MD; Jolin HE; Serrao EM; Haim-Vilmovsky L; Teichmann SA; Rodewald HR; Botto M; Vyse TJ; Fallon PG; Li Z; Withers DR; McKenzie ANJ
    Immunity; 2018 Jun; 48(6):1195-1207.e6. PubMed ID: 29907525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leukotriene C4 Potentiates IL-33-Induced Group 2 Innate Lymphoid Cell Activation and Lung Inflammation.
    Lund SJ; Portillo A; Cavagnero K; Baum RE; Naji LH; Badrani JH; Mehta A; Croft M; Broide DH; Doherty TA
    J Immunol; 2017 Aug; 199(3):1096-1104. PubMed ID: 28667163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.